Does miRNA-155 Promote Cyclooxygenase-2 Expression in Cancer?
dc.contributor.author | Comer, Brian S. | |
dc.contributor.department | Department of Cellular and Integrative Physiology, IU School of Medicine | en_US |
dc.date.accessioned | 2016-05-06T15:19:17Z | |
dc.date.available | 2016-05-06T15:19:17Z | |
dc.date.issued | 2015-11 | |
dc.description.abstract | MicroRNA (miR)-155 and cyclooxygenase (COX)-2 are both elevated in numerous cancers including colorectal cancer. MiR-155 enhances COX-2 expression and is an established regulator of epithelial-mesenchymal transition and inflammation. Inhibition of miR-155 or COX-2 exhibit similar negative effects on tumorigenicity. Thus, it is hypothesized that miR-155 may be a promising target for antagonizing COX-2 expression in colorectal and other cancers. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Comer, B. S. (2015). Does miRNA-155 Promote Cyclooxygenase-2 Expression in Cancer? Drug Development Research, 76(7), 354–356. http://doi.org/10.1002/ddr.21276 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/9543 | |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/ddr.21276 | en_US |
dc.relation.journal | Drug Development Research | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | BIC | en_US |
dc.subject | PTGS-2 | en_US |
dc.subject | MicroRNA-155 | en_US |
dc.subject | cancer | en_US |
dc.title | Does miRNA-155 Promote Cyclooxygenase-2 Expression in Cancer? | en_US |
dc.type | Article | en_US |